An Interview with a Tissue Engineer

From the Guardian: "The human body has tremendous capacity to repair itself after disease or injury. Skin will grow over wounds, while cells in our blood supply are constantly being manufactured in our bone marrow. But there is a limit to the body's ability to replace lost tissue. Cartilage cells are notoriously poor at regrowing after injury, for example. As a result, accidents and illnesses - including cancers - often leave individuals with disfiguring wounds or life-threatening damage to tissue. The aim of Molly Stevens, a nanoscience researcher at Imperial College, London, and founder of the biotech firm Reprogen, is a simple but ambitious one. Working with a team of chemists, cell biologists, surgeons, material scientists and engineers, she is developing techniques that will help the body repair itself when it suffers damage. This is the science of regenerative medicine. ... One approach that we have had considerable success with involves taking quite straightforward materials including simple polymers and using them to boost bone growth in a person. We made them into gels that we could inject into bones. The key to this technique lies with the fact that our bones are covered in a layer of stem cells. We inject our material under that layer and that wakes up those stem cells. They start to multiply and produce lots of new bone."

View the Article Under Discussion: http://www.guardian.co.uk/technology/2010/may/16/bright-idea-get-body-grow-spare-parts

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

International Stem Cell Corporation and The Automation Partnership Enter into Strategic Alliance to Automate Cornea Tissue Production

OCEANSIDE, CA – May 18, 2010 – International Stem Cell Corporation (ISCO.OB), http://www.intlstemcell.com, announced today that it had entered into a strategic alliance with The Automation Partnership (TAP), http://www.automationpartnership.com, to automate and scale up the production of stem cell-derived human corneal tissue. The alliance has been formed to create instrumentation for ISCO and its partners and affiliates to produce development and commercial volumes of donor tissue for cornea transplantation and to reduce the use of animals and animal eyes in safety testing of drugs, chemicals and consumer products.

Cornea-related loss or reduction of vision can be caused by physical injury, infections and degenerative diseases. In cases where cornea replacement is indicated, current medical practice typically involves a one-two hour outpatient procedure under local anesthesia using full or partial corneas from healthy human cadavers. 10 million people worldwide are candidates for such treatment, primarily in Asia and Europe where there is significant quantitative and qualitative shortage of human cornea donation.

Global efforts are underway to transition from the use of live animals and excised animal eyes to test drugs, chemicals and consumer products. For example, Europe’s Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) estimates a need to spend €270M and use 160,000 animals for eye safety testing alone to catch up with the back-log of insufficiently tested agents. In the US, the National Institutes of Health (NIH) and the Environmental Protection Agency (EPA) have launched a five-year program dedicated to finding new, non-animal technologies for toxicity testing of chemical compounds.

ISCO has discovered and filed for patents on a cell culture process for the synthesis of standardized, human, corneal tissue using stem cells. Histology, permeability and optical testing has demonstrated compatibility with natural corneas. Efforts are ongoing to further characterize this tissue and standardize and scale up its synthesis. Automation is necessary to produce sufficient, reproducible tissue for development and commercialization of the therapeutic and toxicity testing applications.

Brian Lundstrom, ISCO’s President, says: “Given the substantial unmet therapeutic and toxicology testing needs for human corneal tissue, ISCO has embarked on a focused effort to advance this technology with international investors, eye clinics, and development and commercialization partners. After reviewing a range of potential cell culture automation companies, we are very pleased that TAP has agreed to contribute their over twenty years of experience towards this goal.”

David Newble, TAP’s CEO says: “TAP has successfully installed and supported over 160 automated cell culture systems worldwide and continues to design new and customize existing equipment for cell culture and other emerging life science applications. The opportunity to join forces with ISCO in the cornea tissue area will enable us to contribute solutions for clear biomedical needs while also creating new technology and knowhow that will be useful in other applications downstream.”

ABOUT INTERNATIONAL STEM CELL CORPORATION (ISCO.OB):
International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products. ISCO’s core technology, parthenogenesis, results in creation of pluripotent human stem cells (hpSCs) from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing sexes, ages and racial groups. This offers the potential to create the first true stem cell bank, UniStemCell™, while avoiding the ethical issue of using fertilized eggs. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology. More information is available at ISCO’s website,
http://www.internationalstemcell.com

To subscribe to receive ongoing corporate communications please click on the following link: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.

About The Automation Partnership
The Automation Partnership (TAP) provides advanced automation systems and services to improve productivity in life science research, development and production.


For over 20 years TAP has been the leader in the design and development of automated cell culture and processing systems with applications in regenerative medicine, discovery research, bioprocess development and biologics production. Systems include SelecT, CompacT SelecT and Cellmate.

In addition, TAP has a strong track record in providing a range of custom automation solutions for biobanking, biological sample management, compound management and advanced high throughput screening applications.

TAP is a privately-owned company with headquarters near Cambridge, UK and a sales and support facility near Wilmington, Delaware, USA.

FORWARD-LOOKING STATEMENTS
Statements pertaining to anticipated technological developments and therapeutic applications, and other opportunities for the company and its subsidiary, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "should," "believes," "plans," "anticipates," "expects," "estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products, uncertainty in the results of clinical trials or regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update these forward-looking statements.

Key Words: Stem Cells, Biotechnology, Parthenogenesis

CONTACTS:
International Stem Cell Corporation
Kenneth C. Aldrich, Chairman
760-940-6383
kaldrich@intlstemcell.com
Or
Brian Lundstrom, President
760-940-6383
bl@intlstemcell.com
Or
The Automation Partnership
Matthew Walker
Head of Communications
+44 1763 227 200
Matthew.walker@automationpartnership.com

Seniors with Sleeping Issues May Suffer Reduced Quality of Life

A new study from Los Angeles has shown that seniors who have a poor quality of sleep also experience depression and other negative symptoms.

Good sleep is important for everyone, but a new study shows that the necessity of quality sleep is especially crucial when it comes to seniors.  A recent study published in the Journal of the American Geriatrics Society showed that if seniors don’t sleep well each night, it could decrease their overall quality of life.

The research focused on residents of Assisted Living Facilities in Los Angeles.  The study followed up with them for 6 months and traced their sleep patterns and emotional states.  The researchers found that the 65% of seniors that reported that they slept poorly also have increased levels of depression and poor quality of life.

Of the seniors studied, sleep was about 5 hours on average.  The people also reported “trouble sleeping” as defined by the Pittsburgh Sleep Quality index. This includes waking up in the middle of the night, or taking more than 30 minutes to fall asleep.  The Pittsburgh Sleep Quality Index is a free test that measures your quality of sleep. It only takes 5 minutes to complete and can be found here.

Those who reported poor sleep in the Los Angeles study were not only more depressed but also more likely to need help with common everyday activities.  Jennifer Martin, PhD, of the University of California, Los Angeles and VA Greater Los Angeles Healthcare System stated, “We cannot conclude that poor sleep truly causes these negative changes; however, future studies should evaluate ways to improve sleep in ALFs to see if sleeping better might improve quality of life, delay functional decline and reduce risk of depression.”

The study does mention that there are effective methods for improving sleep, for example, bright light therapy.  Other methods for improving sleep include spending time outside during the day, resisting alcohol or caffeine before bed and avoiding smoking.

Sources:
medicalnewstoday.com
sleep.pitt.edu
health.com

Discuss this post in Frank Mangano’s forum!

Another Step Forward For Tooth Regeneration

Researchers have regrown teeth in rats by manipulating existing stem cells: "a new technique [can] orchestrate the body's stem cells to migrate to three-dimensional scaffold that is infused with growth factor. This can yield an anatomically correct tooth in as soon as nine weeks once implanted in the mouth. ... These findings represent the first report of regeneration of anatomically shaped tooth-like structures in vivo, and by cell homing without cell delivery. ... By homing stem cells to a scaffold made of natural materials and integrated in surrounding tissue, there is no need to use harvested stem cell lines, or create a an environment outside of the body (e.g., a Petri dish) where the tooth is grown and then implanted once it has matured. The tooth instead can be grown 'orthotopically,' or in the socket where the tooth will integrate with surrounding tissue in ways that are impossible with hard metals or other materials. ... A key consideration in tooth regeneration is finding a cost-effective approach that can translate into therapies for patients who cannot afford or who aren't good candidates for dental implants. Cell-homing-based tooth regeneration may provide a tangible pathway toward clinical translation."

View the Article Under Discussion: http://www.dentistryiq.com/index/display/article-display/0045494294/articles/dentisryiq/industry/2010/05/body_s-stem_cells.html

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

More Data to Ponder on Gender Longevity Differences

From the Max Planck Institute: "Marriage is more beneficial for men than for women - at least for those who want a long life. Previous studies have shown that men with younger wives live longer. While it had long been assumed that women with younger husbands also live longer, [a new study] has shown that this is not the case. Instead, the greater the age difference from the husband, the lower the wife's life expectancy. This is the case irrespective of whether the woman is younger or older than her spouse. ... The mortality risk of a husband who is seven to nine years older than his wife is reduced by eleven percent compared to couples where both partners are the same age. Conversely, a man dies earlier when he is younger than his spouse. For years, researchers have thought that this data holds true for both sexes. They assumed an effect called 'health selection' was in play; those who select younger partners are able to do so because they are healthier and thus already have a higher life expectancy. ... These theories now have to be reconsidered. It appears that the reasons for mortality differences due to the age gap of the spouses remain unclear."

View the Article Under Discussion: http://www.demogr.mpg.de/en/press/1813.htm

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

Micromasonry in Tissue Engineering

A new technique for tissue engineering: "Tissue engineering has long held promise for building new organs to replace damaged livers, blood vessels and other body parts. However, one major obstacle is getting cells grown in a lab dish to form 3-D shapes instead of flat layers. ... To obtain single cells for tissue engineering, researchers have to first break tissue apart, using enzymes that digest the extracellular material that normally holds cells together. However, once the cells are free, it's difficult to assemble them into structures that mimic natural tissue microarchitecture. Some scientists have successfully built simple tissues such as skin, cartilage or bladder on biodegradable foam scaffolds. ... That works, but it often lacks a controlled microarchitecture. You don't get tissues with the same complexity as normal tissues. ... Researchers [have] come up with a new way to overcome that challenge, by encapsulating living cells in cubes and arranging them into 3-D structures, just as a child would construct buildings out of blocks. The new technique, dubbed 'micromasonry,' employs a gel-like material that acts like concrete, binding the cell 'bricks' together as it hardens. ... You can reproduce this in any lab. It's very simple. ... The short-term next step is really looking at different cell types and the viability of tissue growth."

View the Article Under Discussion: http://web.mit.edu/newsoffice/2010/tissue-legos-0513.html

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

Creating Inner-Ear Cells

Via EurekAlert: "Humans are born with 30,000 cochlear and vestibular hair cells per ear. (By contrast, one retina harbors about 120 million photoreceptors.) When a significant number of these cells are lost or damaged, hearing loss occurs. The major reason for hearing loss and certain balance disorders is that - unlike other species such as birds - humans and other mammals are unable to spontaneously regenerate these hearing cells. ... After years of lab work, researchers [have] found a way to develop mouse cells that look and act just like the animal's inner-ear hair cells - the linchpin to our sense of hearing and balance - in a petri dish. If they can further perfect the recipe to generate hair cells in the millions, it could lead to significant scientific and clinical advances along the path to curing deafness in the future. ... While researchers will ultimately need human hair cells, the mouse version is a good model for the initial phases of experimentation, he said. In addition to using mouse embryonic stem cells, the researchers used fibroblasts that had been reprogrammed to behave like stem cells: These are known as induced pluripotent stem cells, or iPS cells."

View the Article Under Discussion: http://www.eurekalert.org/pub_releases/2010-05/sumc-at051010.php

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

CR Mimetics and the Definition of Insanity

From the SENS Foundation: "To date, all successful interventions into the biological aging process in experimental animals have entailed modulation of basic metabolic pathways, generally through genetic or dietary manipulation. Of these, the earliest, most well-studied, and arguably the most robust, is Calorie restriction (CR): the reduction in dietary energy intake, without compromise of essential nutrients. With few exceptions, CR retards the biological rate of aging in nearly every species and strain of organisms in which it has been tested, ranging from rotifers, through small multicellular invertebrates, and most extensively to laboratory rodents; and although inconclusive, recent evidence also supports its effectiveness in dogs and nonhuman primates. Moreover, while necessarily preliminary, a growing body of human research has reported that rigorous CR, when practiced by previously normal-weight adults, results in physiological, functional, and perhaps even structural changes consistent with its translation to the human case. ... But despite the initial attractiveness of the notion; its strong theoretical basis; the high level of scientific interest that it has garnered; the launching of biotech startups originating in CR mimetic research; and the popularization and commercial exploitation of the concept by the dietary supplement industry - despite all of these drivers, the ensuing decade and a half or more of CR mimetic research have thus far been fruitless. Initially-promising compounds have failed to extend lifespan, while surprising findings have preempted the further investigation of what might otherwise have been novel targets for CR mimetics."

View the Article Under Discussion: http://www.sens.org/node/777

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

The Challenge of Longevity

From QFinance: "Big business and governments are already grappling with the uncomfortable side effects of increasing longevity. According to actuaries, the present generation has gained the equivalent of 12 minutes an hour or a 20% increase in average lifespan by comparison with the previous generation. The impact of this is felt first and foremost in the pensions arena, with businesses having to run harder just to stand still as far as their pension scheme deficits are concerned. But it is felt too by governments across Europe as they struggle to pay out meaningful state pension benefits against the headwind imposed by the fact that the ratio of those in work to those on pension is getting more and more out of balance. The impact of increased longevity is felt too in the health systems, where the diseases and ailments of old age take an increasing toll on a country's medical resources. These problems might seem fairly intractable, or at least extremely difficult and challenging in their own right, but it could be just the tip of the iceberg, according to the renowned longevity specialist Dr Aubrey de Grey, Chief Scientist at the charity SENS, which specializes in promoting research that aims to 'defeat ageing.' Dr de Grey is famous for asserting that the first person to enjoy a four-digit lifespan is probably already in his or her middle years. Before I give a rapid summary of his reasoning - those interested in learning more can watch a video of one of his presentations at the SENS website - it is worth saying that if de Grey is right, then instead of exacerbating the pensions problem, as I suggested earlier, it will probably make the problem vanish like a puff of smoke. Provided society stays reasonably open, people will have more than enough time to acquire independent means. The magic of compound arithmetic will be very much in their favor. Start small, watch it grow, where's the hurry?"

View the Article Under Discussion: http://www.qfinance.com/blogs/anthony-harrington/2010/05/05/the-challenge-of-longevity

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

Testing the Mitochondrial Free Radical Theory of Aging

An open access paper from Impact Aging: "The Mitochondrial Free Radical Theory of Aging (MFRTA) is currently one of the most widely accepted theories used to explain aging. From MFRTA three basic predictions can be made: long-lived individuals or species should produce fewer mitochondrial Reactive Oxygen Species (mtROS) than short-lived individuals or species; a decrease in mtROS production will increase lifespan; and an increase in mtROS production will decrease lifespan. It is possible to add a further fourth prediction: if ROS is controlling longevity separating these parameters through selection would be impossible. These predictions have been tested in Drosophila melanogaster." Where I think the researchers go wrong here lies in not accounting for how differences in mitochondrial composition might affect the level of damage caused by a given amount of ROS. There is a strong argument that species life span differences have a lot to do with how resilient mitochondria are to damage. But read the paper anyway; it's a good introduction to thinking about the mitochondrial free radical theory of aging.

View the Article Under Discussion: http://www.impactaging.com/papers/v2/n4/full/100137.html

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

The Public View of Longevity Science

As this Independent article shows, the public view of longevity science extends little beyond the goal of slowing aging espoused by mainstream researchers, and conflates the fakery and fraud of "anti-aging" cosmetics companies with real science: "We spend millions of pounds each year on anti-ageing tonics, potions, vitamins and creams, trying to stave off the ravages of the years. But our genetic inheritance trumps all other factors in determining how well we age and how long we live. By unravelling the genetic determinants of longevity, scientists believe they will be able to manipulate them to add not only years to life, but also life to years. An elixir of youth remains a distant dream but medicines to help us live longer and better are moving closer. At a conference this week, Turning Back the Clock, organised by the Royal Society, researchers described the progress that has been made in the science of ageing. At least 10 gene mutations have been identified that extend the lifespan of mice by up to half, and in humans several genetic variants have been linked with longevity. They include a family of genes dubbed the sirtuins, which one Italian study found occurred more commonly in centenarian men than in the general population. A subsidiary of drug giant GlaxoSmithKline is now looking at sirtuins, and their association with a range of age-related diseases including type 2 diabetes and cancers."

View the Article Under Discussion: http://www.independent.co.uk/news/science/has-the-elixir-of-youth-come-of-age-1971341.html

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

Insulin Resistance Accelerates Atherosclerosis

Another consequence of the overeating and lack of exercise that leads to metabolic syndrome and diabetes: "In people with insulin resistance or full-blown diabetes, an inability to keep blood sugar levels under control isn't the only problem by far. A new report [shows] that our arteries suffer the effects of insulin resistance, too, just for entirely different reasons. ... Earlier studies showed that in the context of systemic insulin resistance, blood vessels become resistant, too. Doctors also knew that insulin resistance and the high insulin levels to which it leads are independent risk factors for vascular disease. But it wasn't clear if arteries become diseased because they can't respond to insulin or because they get exposed to too much of it. Now comes evidence in favor of the former explanation. ... mice prone to atherosclerosis fare much worse when the linings of their arteries can't respond to insulin. The animals' insulin-resistant arteries develop plaques that are twice the size of those on normal arteries. Insulin-resistant blood vessels don't open up as well, and levels of a protein known as VCAM-1 go up in them, too. VCAM-1 belongs to a family of adhesion molecules [which sit on the endothelium and bind] white blood cells. ... Those cells can enter the artery wall, where they start taking up cholesterol, and an early plaque is born. ... The results provide definitive evidence that loss of insulin signaling in the endothelium, in the absence of competing systemic risk factors, accelerates atherosclerosis."

View the Article Under Discussion: http://www.eurekalert.org/pub_releases/2010-05/cp-yam042810.php

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

Parkinson's as Autophagy Failure

Autophagy is important in determining life span, probably because of its role in clearing out damaged mitochondria (a process known as mitophagy) before they can cause other forms of harm. Here is evidence for that view in the form of a link between Parkinson's disease and autophagy: "Mutations that cause Parkinson's disease prevent cells from destroying defective mitochondria ... Defects in the ubiquitin ligase Parkin are linked to early-onset cases of this neurodegenerative disorder. The wild-type protein promotes the removal of impaired mitochondria by a specialized version of the autophagy pathway called mitophagy, delivering mitochondria to the lysosomes for degradation. Mitochondria are often dysfunctional in Parkinson's disease ... cells expressing mutant forms of Parkin failed to clear their mitochondria after the organelles were damaged. Different mutations blocked mitophagy at distinct steps: mitochondria accumulated in the perinuclear region of cells expressing Parkin lacking its ubiquitin ligase activity, for example. The researchers found that ubiquitination of defective mitochondria by Parkin normally recruits the autophagy proteins HDAC6 and p62 to clear these mitochondrial aggregates. ... The clearance of defective mitochondria is therefore similar to the removal of damaged proteins, another autophagic process that goes wrong in Parkinson's disease resulting in the accumulation of toxic protein aggregates. Both pathways rely on microtubules, HDAC6, and p62, [providing] a common link between the two main features of the neurodegenerative disorder."

View the Article Under Discussion: http://www.eurekalert.org/pub_releases/2010-05/rup-mtc050610.php

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

Parkinson’s as Autophagy Failure

Autophagy is important in determining life span, probably because of its role in clearing out damaged mitochondria (a process known as mitophagy) before they can cause other forms of harm. Here is evidence for that view in the form of a link between Parkinson's disease and autophagy: "Mutations that cause Parkinson's disease prevent cells from destroying defective mitochondria ... Defects in the ubiquitin ligase Parkin are linked to early-onset cases of this neurodegenerative disorder. The wild-type protein promotes the removal of impaired mitochondria by a specialized version of the autophagy pathway called mitophagy, delivering mitochondria to the lysosomes for degradation. Mitochondria are often dysfunctional in Parkinson's disease ... cells expressing mutant forms of Parkin failed to clear their mitochondria after the organelles were damaged. Different mutations blocked mitophagy at distinct steps: mitochondria accumulated in the perinuclear region of cells expressing Parkin lacking its ubiquitin ligase activity, for example. The researchers found that ubiquitination of defective mitochondria by Parkin normally recruits the autophagy proteins HDAC6 and p62 to clear these mitochondrial aggregates. ... The clearance of defective mitochondria is therefore similar to the removal of damaged proteins, another autophagic process that goes wrong in Parkinson's disease resulting in the accumulation of toxic protein aggregates. Both pathways rely on microtubules, HDAC6, and p62, [providing] a common link between the two main features of the neurodegenerative disorder."

View the Article Under Discussion: http://www.eurekalert.org/pub_releases/2010-05/rup-mtc050610.php

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/

US Patent: Isolation and use of solid tumor stem cells

Isolation and use of solid tumor stem cells, United States Patent 7,713,710. [FreePatentsOnline][PatentStorm].
Publication Date: May 11, 2010.
Inventors: Clarke; Michael F. (Ann Arbor, MI), Morrison; Sean J. (Ann Arbor, MI), Wicha; Max S. (Ann Arbor, MI), Al-Hajj; Muhammad (Ann Arbor, MI).
Assignee: The Regents of the University of Michigan (Ann Arbor, MI) .
Appl. No.: 11/753,191
Filed: May 24, 2007
Abstract:

A small percentage of cells within an established tumor have the properties of stem cells. These solid tumor stem cells give rise both to more tumor stem cells and to the majority of cells in the tumor that have lost the capacity for extensive proliferation and the ability to give rise to new tumors. The solid tumor heterogeneity reflects the presence of tumor cell progeny arising from a solid tumor stem cell. This discovery is the basis for solid tumor stem cell compositions, methods for distinguishing functionally different populations of tumor cells, methods for using these tumor cell populations for studying the effects of therapeutic agents on tumor growth, and methods for identifying and testing novel anti-cancer therapies directed to solid tumor stem cells.

Parent Case Text:

CLAIM OF PRIORITY
This application is a Continuation of U.S. patent application Ser. No. 11/150,073, filed Jun. 10, 2005, which is a Continuation of U.S. patent application Ser. No. 09/920,517, filed Aug. 1, 2001, now U.S. Pat. No. 6,984,522, which claims priority to U.S. provisional applications Ser. No. 60/222,794, filed Aug. 3, 2000, and Ser. No. 60/240,317, filed Oct. 13, 2000, all of which are herein incorporated by reference in their entireties.

Google patents entry for Application Number 11/753,191 (The application that led to patent 7,713,710. The filing date was 24 May 2007).

Google patents entry for Application Number 11/150,073 (See Parent Case Text above: the filing date was 10 June 2005).

Google patents entry for Patent Number 6,984.522 (See Parent Case Text above: the filing date was 1 August, 2001 and the issue date was 10 Jan 2006). [FreePatentsOnline][PatentStorm].

Comment:

Not mentioned in the Parent Case Text above is United States Patent 7,115,360. [FreePatentsOnline][PatentStorm]. This patent was issued October 3, 2006 and filed on August 2, 2001.

The Parent Case Text for patent 7,115,360:

CLAIM OF PRIORITY
This patent is the United States national stage of PCT patent application PCT/US01/24243, published Feb. 14, 2002 as WO 02/12447, which is a continuation of U.S. Ser. No. 09/920,517, filed Aug. 1, 2001, now U.S. Pat. No. 6,984,522. This patent also claims priority to provisional patent applications U.S. Ser. Nos. 60/222,794, filed Aug. 3, 2000, and 60/240,317, Oct. 13, 2000.

Information about this patent was found via a Google search for "Isolation and use of solid tumor stem cells".

Your Cholesterol Levels Can Tell Doctors a Lot About You

A new report from the Mayo Clinic points out that your cholesterol levels can reflect details about your overall health including the quality of your diet and exercise plan.

Your cholesterol levels can tell you more than just your levels of triglycerides!  Researchers have now determined that cholesterol levels can now also report on a person’s lifestyle choices.  The Mayo Clinic Health Letter recently released their findings that a person’s level of overall health is reflected in their good and bad cholesterol levels.

While cholesterol is normal for our bodies and is found in all of our cells, too much cholesterol can put your blood vessels at risk.  Bad cholesterol can cause our blood vessels to narrow and blood flow to be restricted.  Obviously this is a problem that can lead to health problems like heart attack and stroke.

If you are looking to reduce your LDL levels, be sure to eat less saturated fats, trans fats and increase your intake of healthy fats like extra virgin olive oil and flax seed oil.  Also foods high in soluble fiber, such as oatmeal,  are recommended to reduce the LDL.

HDL levels reflect good cholesterol. If you have low HDL, this fact means that you may very well have a sedentary lifestyle.  Also, more than likely, you don’t exercise enough.  Exercising, of course, has a number of health benefits including raising your levels of good cholesterol.

According to P.K. Shah, MD, director of cardiology at Cedars-Sinai Medical Center in Los Angeles, “Boosting HDL is the next frontier in heart disease prevention.”  Reducing your calories, sugar, and alcohol consumption can also improve your HDL levels.

Fish oil can also go a long way in helping people with low HDL.  Other suggestions include red yeast rice supplementation, taking a niacin supplement, and eating foods that have lower glycemic levels.

Sources:
medicalnewstoday.com
webmd.com

Discuss this post in Frank Mangano’s forum!

How Emotions Play a Role in Overeating

Temple’s Center for Obesity Research is studying the link between emotional eating and the ability for people to keep weight off long-term.

It is no secret that people trying to lose weight seek to control their eating habits.  However, many people don’t realize that their emotions play into their ability to control their food choices.  Unfortunately, many weight loss programs neglect to address this issue.

While dieters may try to choose better foods and exercise, often they are unable to do so effectively.  If people can’t cope with their emotions, how can they really change their eating habits?  Emotions can make people give up on their diets and turn to things like junk food.

A recent study at Temple’s Center for Obesity Research seeks to answer this question by putting together a treatment that teaches people skills to address emotional eating.  This study is funded by the National Institute of Health.

The idea behind this new treatment program is that emotional skills will be taught to people who are chronic overeaters.  This education will be added to this weight loss treatment program that focuses on behavior.  The program teaches different techniques that seek to break the cycle of emotional eating. Researchers are interested in creating a program that addresses emotions and helps participants to achieve long-term weight loss success.

Janet Williams is part of one of the first groups to go through this treatment. She stated, “”The program doesn’t just help you identify when you eat,” said Williams. “It helps you recognize triggers that make you eat, to help you break that cycle of reaching for food every time you feel bored, or frustrated, or sad.”

Sources:
medicalnewstoday.com

Discuss this post in Frank Mangano’s forum!

More Evidence that Environmental Factors Contribute to Cancer

A recent presidential study has concluded that the carcinogens in the environment are contributing to high cancer rates.

As time goes on and on, more sources point to the fact that cancer is caused by carcinogens in the environment.  In fact, a new report was just released that was completed by a expert panel that currently advises Barack Obama. This panel, called the President’s Cancer Panel (or PCP), was set up in the 1970’s.

This 240 page report, which is available for the public to download, is called “Reducing Environmental Cancer Risk: What We Can Do Now.”  The report concludes that the known carcinogens in the environment are increasing, and they need to be dealt with by the government.

Dr. LaSalle D. Lefall, Jr. chairperson of the PCP stated, “There remains a great deal to be done to identify the many existing but unrecognized environmental carcinogens and eliminate those that are known from our daily lives – our workplaces, schools and homes.”  According to the report, people are exposed to up to 80,000 chemicals each day and many of them are completely unregulated.  These chemicals include radon, formaldehyde, and benzene.  Oftentimes people are completely unaware that they are being exposed to these cancer-causing chemicals.

The panel urged the government to take better steps to reduce people’s exposure to toxins by doing things like improving the understanding about these toxins, developing a better policy towards them and raising awareness. These are just a few of the suggestions made by the PCP.

The good news, however, is that researchers are learning more all the time about natural ways to treat cancer.  For example, exercise is an easy and effective way to fight cancer.  Additionally, turmeric is an extremely powerful herb that can actually kill cancer cells.  Turmeric contains the chemical curcumin.  Recent tests by the Cork Cancer Research Center show that curcumin can actually destroy cancer cells.

Sources:
news.bbc.co.uk
medicalnewstoday.com

Discuss this post in Frank Mangano’s forum!

Acupuncture Seminar & Workshop (May 14-16, 2010, New York, New York, USA, North America)

Cliquez pour écouter ce texte THE NEW YORK ACADEMY OF MEDICINE Jointly Sponsored with the INTERNATIONAL COLLEGE OF ACUPUNCTURE & ELECTRO-THERAPEUTICS, Permanently Chartered by the University of the State of New York, State Education Department Seminar & Workshop on ACUPUNCTURE & ELECTRO-THERAPEUTICS in Clinical Practice Licensed Physicians and Dentists can earn credit hours toward the Acupuncture Certificate to practice acupuncture (300 credit hours). 25 credit hours can be earned by attending one 3-day weekend (Friday - Sunday) session.

Acupuncture Seminar & Workshop (May 14-16, 2010, New York, New York, USA, North America)

Cliquez pour écouter ce texte THE NEW YORK ACADEMY OF MEDICINE Jointly Sponsored with the INTERNATIONAL COLLEGE OF ACUPUNCTURE & ELECTRO-THERAPEUTICS, Permanently Chartered by the University of the State of New York, State Education Department Seminar & Workshop on ACUPUNCTURE & ELECTRO-THERAPEUTICS in Clinical Practice Licensed Physicians and Dentists can earn credit hours toward the Acupuncture Certificate to practice acupuncture (300 credit hours). 25 credit hours can be earned by attending one 3-day weekend (Friday - Sunday) session.